Article Details

AIM announces principal investigator for Ampligen, FluMist clinical study | Markets Insider

Retrieved on: 2025-02-28 15:45:26

Tags for this article:

Click the tags to see associated articles and topics

AIM announces principal investigator for Ampligen, FluMist clinical study | Markets Insider. View article details on hiswai:

Excerpt

News for AstraZeneca · AIM announces principal investigator for Ampligen ... AstraZeneca's (AZN) FluMist as an intranasal vaccine for influenza ...

Article found on: markets.businessinsider.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up